|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004482,
umls-concept:C0030946,
umls-concept:C0035020,
umls-concept:C0042384,
umls-concept:C0087111,
umls-concept:C0103647,
umls-concept:C0332281,
umls-concept:C0439658,
umls-concept:C0439858,
umls-concept:C0475208,
umls-concept:C1446409,
umls-concept:C1707719
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-4-12
|
|
pubmed:abstractText |
To analyze disease-free survival in patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis (AAV) treated with cyclophosphamide only or switched to azathioprine after 3 months of full remission while taking cyclophosphamide.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
269-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15077271-Adult,
pubmed-meshheading:15077271-Aged,
pubmed-meshheading:15077271-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:15077271-Azathioprine,
pubmed-meshheading:15077271-Cyclophosphamide,
pubmed-meshheading:15077271-Disease-Free Survival,
pubmed-meshheading:15077271-Female,
pubmed-meshheading:15077271-Follow-Up Studies,
pubmed-meshheading:15077271-Humans,
pubmed-meshheading:15077271-Immunosuppressive Agents,
pubmed-meshheading:15077271-Male,
pubmed-meshheading:15077271-Middle Aged,
pubmed-meshheading:15077271-Myeloblastin,
pubmed-meshheading:15077271-Prospective Studies,
pubmed-meshheading:15077271-Recurrence,
pubmed-meshheading:15077271-Remission Induction,
pubmed-meshheading:15077271-Serine Endopeptidases,
pubmed-meshheading:15077271-Vasculitis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
|
|
pubmed:affiliation |
University Hospital Maastricht, Maastricht, The Netherlands. m.slot@immuno.unimaas.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
